Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.11B |
| 2 |
Snowflake
SNOW
|
+$1.67B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.61B |
| 4 |
Shopify
SHOP
|
+$1.42B |
| 5 |
Royalty Pharma
RPRX
|
+$1.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$2.27B |
| 2 |
Amazon
AMZN
|
+$2.09B |
| 3 |
Vipshop
VIPS
|
+$1.28B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.27B |
| 5 |
Alibaba
BABA
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.57% |
| 2 | Healthcare | 9.66% |
| 3 | Financials | 8.97% |
| 4 | Communication Services | 8.91% |
| 5 | Consumer Discretionary | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
1701
DELISTED
Adaptimmune Therapeutics
ADAP
| $25.1M | ﹤0.01% |
4,723,562
-663,926
| -12% | -$3.8M |
|
1702
Arrowhead Research
ARWR
$12.2B
| $25M | ﹤0.01% |
377,209
-159,270
| -30% | -$12.4M |
|
1703
Vanguard ESG International Stock ETF
VSGX
$6.84B
| $25M | ﹤0.01% |
407,250
+97,715
| +32% | +$6.02M |
|
1704
JELD-WEN Holding
JELD
$171M
| $25M | ﹤0.01% |
901,485
-46,189
| -5% | -$1.28M |
|
1705
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.29B
| $25M | ﹤0.01% |
528,462
-27,775
| -5% | -$1.27M |
|
|
CHY
1706
Calamos Convertible and High Income Fund
CHY
$1.09B
| $25M | ﹤0.01% |
1,673,547
+3,455
| +0.2% | +$51.6K |
|
1707
DNP Select Income Fund
DNP
$4.11B
| $24.9M | ﹤0.01% |
2,523,880
-286,330
| -10% | -$2.93M |
|
1708
Federal Signal
FSS
$7.51B
| $24.9M | ﹤0.01% |
650,799
+34,378
| +6% | +$1.24M |
|
|
MGLN
1709
DELISTED
Magellan Health Services, Inc.
MGLN
| $24.9M | ﹤0.01% |
266,970
+193,786
| +265% | +$18.2M |
|
1710
Principal Spectrum Preferred Securities Active ETF
PREF
$1.78B
| $24.9M | ﹤0.01% |
1,220,899
+654,894
| +116% | +$13.5M |
|
1711
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.28B
| $24.9M | ﹤0.01% |
590,174
+360,655
| +157% | +$14.7M |
|
1712
Deckers Outdoor
DECK
$12.7B
| $24.8M | ﹤0.01% |
450,930
-52,692
| -10% | -$2.81M |
|
1713
Textron
TXT
$15.1B
| $24.8M | ﹤0.01% |
441,507
-44,722
| -9% | -$2.27M |
|
|
FPRX
1714
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $24.8M | ﹤0.01% |
657,354
+615,789
| +1,482% | +$15.4M |
|
|
ZUO
1715
DELISTED
Zuora, Inc.
ZUO
| $24.7M | ﹤0.01% |
1,671,122
+323,506
| +24% | +$4.82M |
|
1716
Natera
NTRA
$45B
| $24.7M | ﹤0.01% |
243,232
-15,170
| -6% | -$1.66M |
|
1717
Wabtec
WAB
$50.1B
| $24.6M | ﹤0.01% |
310,665
+55,321
| +22% | +$4.29M |
|
1718
Invesco BuyBack Achievers ETF
PKW
$1.79B
| $24.6M | ﹤0.01% |
291,993
+63,704
| +28% | +$5.05M |
|
1719
Steris
STE
$23B
| $24.5M | ﹤0.01% |
128,749
-161,669
| -56% | -$30M |
|
1720
Marriott Vacations Worldwide
VAC
$4.15B
| $24.5M | ﹤0.01% |
140,647
+11,548
| +9% | +$1.8M |
|
1721
Invesco Dorsey Wright Technology Momentum ETF
PTF
$668M
| $24.5M | ﹤0.01% |
511,152
-79,641
| -13% | -$4M |
|
1722
MasTec
MTZ
$23.3B
| $24.5M | ﹤0.01% |
261,245
+14,777
| +6% | +$1.26M |
|
1723
Darling Ingredients
DAR
$10.2B
| $24.5M | ﹤0.01% |
332,615
-54,817
| -14% | -$3.77M |
|
1724
Columbia Diversified Fixed Income Allocation ETF
DIAL
$388M
| $24.4M | ﹤0.01% |
1,157,628
-16,087
| -1% | -$347K |
|
|
ENLC
1725
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $24.4M | ﹤0.01% |
5,699,007
-3,416,686
| -37% | -$14.8M |
|
Similar funds
Morgan Stanley's Q1 2021 Portfolio in Review
As of Q1 2021, Morgan Stanley held 7,749 positions worth $681B, up 5.1% from $647B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2021 filing shows 618 new, 3,173 increased, 3,213 reduced and 189 closed positions. Its largest new stake was Coupang: 16,573,913 shares worth $818M. The largest sale was Paramount Global Class B, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2021 buy was Coupang: 16,573,913 shares worth $818M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $3.11B increase.
- Morgan Stanley's biggest Q1 2021 reduction was Paramount Global Class B, cutting an estimated $2.27B.
- Morgan Stanley fully exited Tiffany & Co. in Q1 2021, selling an estimated $318M.
- Morgan Stanley's ten largest holdings make up 16% of its $681B portfolio in Q1 2021.
- Morgan Stanley opened 618 new positions and closed 189 in Q1 2021.
- Morgan Stanley's portfolio value rose 5.1% quarter-over-quarter to $681B.
Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.